Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 4 |
Forrest at al. (procyclic) | no | yes: 6 |
Silverman et al. | no | yes: 2 |
Pissara et al. | yes | yes: 18 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 4 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 8 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 13 |
NetGPI | no | yes: 0, no: 13 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 4 |
GO:0005737 | cytoplasm | 2 | 4 |
GO:0043226 | organelle | 2 | 4 |
GO:0043227 | membrane-bounded organelle | 3 | 4 |
GO:0043229 | intracellular organelle | 3 | 4 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 4 |
GO:0110165 | cellular anatomical entity | 1 | 4 |
GO:0031974 | membrane-enclosed lumen | 2 | 1 |
GO:0031981 | nuclear lumen | 5 | 1 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 1 |
GO:0043233 | organelle lumen | 3 | 1 |
GO:0070013 | intracellular organelle lumen | 4 | 1 |
GO:0097014 | ciliary plasm | 5 | 1 |
GO:0099568 | cytoplasmic region | 3 | 1 |
Related structures:
AlphaFold database: Q4Q9T3
Term | Name | Level | Count |
---|---|---|---|
GO:0006468 | protein phosphorylation | 5 | 14 |
GO:0006793 | phosphorus metabolic process | 3 | 14 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 14 |
GO:0006807 | nitrogen compound metabolic process | 2 | 14 |
GO:0006810 | transport | 3 | 4 |
GO:0006897 | endocytosis | 5 | 4 |
GO:0007165 | signal transduction | 2 | 4 |
GO:0008152 | metabolic process | 1 | 14 |
GO:0009987 | cellular process | 1 | 14 |
GO:0016192 | vesicle-mediated transport | 4 | 4 |
GO:0016310 | phosphorylation | 5 | 14 |
GO:0018105 | peptidyl-serine phosphorylation | 6 | 4 |
GO:0018193 | peptidyl-amino acid modification | 5 | 4 |
GO:0018209 | peptidyl-serine modification | 6 | 4 |
GO:0019538 | protein metabolic process | 3 | 14 |
GO:0036211 | protein modification process | 4 | 14 |
GO:0043170 | macromolecule metabolic process | 3 | 14 |
GO:0043412 | macromolecule modification | 4 | 14 |
GO:0044237 | cellular metabolic process | 2 | 14 |
GO:0044238 | primary metabolic process | 2 | 14 |
GO:0050789 | regulation of biological process | 2 | 4 |
GO:0050794 | regulation of cellular process | 3 | 4 |
GO:0051179 | localization | 1 | 4 |
GO:0051234 | establishment of localization | 2 | 4 |
GO:0065007 | biological regulation | 1 | 4 |
GO:0071704 | organic substance metabolic process | 2 | 14 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 14 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 14 |
GO:0003824 | catalytic activity | 1 | 14 |
GO:0004672 | protein kinase activity | 3 | 14 |
GO:0004674 | protein serine/threonine kinase activity | 4 | 10 |
GO:0005488 | binding | 1 | 14 |
GO:0005524 | ATP binding | 5 | 14 |
GO:0016301 | kinase activity | 4 | 14 |
GO:0016740 | transferase activity | 2 | 14 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 14 |
GO:0016773 | phosphotransferase activity, alcohol group as acceptor | 4 | 14 |
GO:0017076 | purine nucleotide binding | 4 | 14 |
GO:0030554 | adenyl nucleotide binding | 5 | 14 |
GO:0032553 | ribonucleotide binding | 3 | 14 |
GO:0032555 | purine ribonucleotide binding | 4 | 14 |
GO:0032559 | adenyl ribonucleotide binding | 5 | 14 |
GO:0035639 | purine ribonucleoside triphosphate binding | 4 | 14 |
GO:0036094 | small molecule binding | 2 | 14 |
GO:0043167 | ion binding | 2 | 14 |
GO:0043168 | anion binding | 3 | 14 |
GO:0097159 | organic cyclic compound binding | 2 | 14 |
GO:0097367 | carbohydrate derivative binding | 2 | 14 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 14 |
GO:1901265 | nucleoside phosphate binding | 3 | 14 |
GO:1901363 | heterocyclic compound binding | 2 | 14 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 378 | 382 | PF00656 | 0.517 |
CLV_NRD_NRD_1 | 111 | 113 | PF00675 | 0.505 |
CLV_NRD_NRD_1 | 156 | 158 | PF00675 | 0.388 |
CLV_NRD_NRD_1 | 250 | 252 | PF00675 | 0.399 |
CLV_NRD_NRD_1 | 328 | 330 | PF00675 | 0.555 |
CLV_NRD_NRD_1 | 396 | 398 | PF00675 | 0.618 |
CLV_NRD_NRD_1 | 53 | 55 | PF00675 | 0.480 |
CLV_PCSK_KEX2_1 | 156 | 158 | PF00082 | 0.377 |
CLV_PCSK_KEX2_1 | 250 | 252 | PF00082 | 0.399 |
CLV_PCSK_KEX2_1 | 328 | 330 | PF00082 | 0.526 |
CLV_PCSK_KEX2_1 | 336 | 338 | PF00082 | 0.523 |
CLV_PCSK_KEX2_1 | 396 | 398 | PF00082 | 0.618 |
CLV_PCSK_KEX2_1 | 434 | 436 | PF00082 | 0.475 |
CLV_PCSK_KEX2_1 | 440 | 442 | PF00082 | 0.526 |
CLV_PCSK_KEX2_1 | 490 | 492 | PF00082 | 0.599 |
CLV_PCSK_PC1ET2_1 | 336 | 338 | PF00082 | 0.515 |
CLV_PCSK_PC1ET2_1 | 434 | 436 | PF00082 | 0.504 |
CLV_PCSK_PC1ET2_1 | 440 | 442 | PF00082 | 0.554 |
CLV_PCSK_PC1ET2_1 | 490 | 492 | PF00082 | 0.599 |
CLV_PCSK_PC7_1 | 332 | 338 | PF00082 | 0.452 |
CLV_PCSK_SKI1_1 | 161 | 165 | PF00082 | 0.328 |
CLV_PCSK_SKI1_1 | 185 | 189 | PF00082 | 0.446 |
CLV_PCSK_SKI1_1 | 21 | 25 | PF00082 | 0.396 |
CLV_PCSK_SKI1_1 | 229 | 233 | PF00082 | 0.392 |
CLV_PCSK_SKI1_1 | 282 | 286 | PF00082 | 0.377 |
CLV_PCSK_SKI1_1 | 290 | 294 | PF00082 | 0.334 |
CLV_PCSK_SKI1_1 | 304 | 308 | PF00082 | 0.400 |
CLV_PCSK_SKI1_1 | 328 | 332 | PF00082 | 0.471 |
CLV_PCSK_SKI1_1 | 85 | 89 | PF00082 | 0.565 |
DEG_APCC_DBOX_1 | 156 | 164 | PF00400 | 0.377 |
DEG_APCC_DBOX_1 | 250 | 258 | PF00400 | 0.416 |
DEG_SCF_FBW7_2 | 291 | 297 | PF00400 | 0.292 |
DOC_CKS1_1 | 291 | 296 | PF01111 | 0.434 |
DOC_CKS1_1 | 401 | 406 | PF01111 | 0.601 |
DOC_CYCLIN_RxL_1 | 311 | 319 | PF00134 | 0.463 |
DOC_CYCLIN_RxL_1 | 332 | 341 | PF00134 | 0.384 |
DOC_CYCLIN_yCln2_LP_2 | 366 | 372 | PF00134 | 0.608 |
DOC_MAPK_gen_1 | 197 | 205 | PF00069 | 0.379 |
DOC_MAPK_gen_1 | 218 | 225 | PF00069 | 0.322 |
DOC_MAPK_gen_1 | 336 | 342 | PF00069 | 0.481 |
DOC_MAPK_gen_1 | 42 | 52 | PF00069 | 0.447 |
DOC_MAPK_MEF2A_6 | 43 | 52 | PF00069 | 0.442 |
DOC_PP1_RVXF_1 | 210 | 216 | PF00149 | 0.377 |
DOC_PP1_RVXF_1 | 312 | 319 | PF00149 | 0.456 |
DOC_PP2B_LxvP_1 | 340 | 343 | PF13499 | 0.431 |
DOC_PP2B_LxvP_1 | 366 | 369 | PF13499 | 0.574 |
DOC_PP4_FxxP_1 | 494 | 497 | PF00568 | 0.588 |
DOC_USP7_MATH_1 | 360 | 364 | PF00917 | 0.727 |
DOC_USP7_MATH_1 | 458 | 462 | PF00917 | 0.629 |
DOC_USP7_MATH_1 | 486 | 490 | PF00917 | 0.838 |
DOC_USP7_UBL2_3 | 300 | 304 | PF12436 | 0.589 |
DOC_USP7_UBL2_3 | 51 | 55 | PF12436 | 0.406 |
DOC_WW_Pin1_4 | 290 | 295 | PF00397 | 0.438 |
DOC_WW_Pin1_4 | 400 | 405 | PF00397 | 0.595 |
DOC_WW_Pin1_4 | 493 | 498 | PF00397 | 0.626 |
LIG_14-3-3_CanoR_1 | 112 | 116 | PF00244 | 0.511 |
LIG_14-3-3_CanoR_1 | 156 | 161 | PF00244 | 0.387 |
LIG_14-3-3_CanoR_1 | 314 | 319 | PF00244 | 0.471 |
LIG_14-3-3_CanoR_1 | 337 | 343 | PF00244 | 0.433 |
LIG_14-3-3_CanoR_1 | 383 | 388 | PF00244 | 0.622 |
LIG_14-3-3_CanoR_1 | 396 | 400 | PF00244 | 0.553 |
LIG_14-3-3_CanoR_1 | 462 | 468 | PF00244 | 0.543 |
LIG_AP2alpha_1 | 33 | 37 | PF02296 | 0.428 |
LIG_APCC_ABBAyCdc20_2 | 180 | 186 | PF00400 | 0.377 |
LIG_BRCT_BRCA1_1 | 255 | 259 | PF00533 | 0.377 |
LIG_BRCT_BRCA1_1 | 314 | 318 | PF00533 | 0.410 |
LIG_BRCT_BRCA1_1 | 348 | 352 | PF00533 | 0.552 |
LIG_BRCT_BRCA1_1 | 483 | 487 | PF00533 | 0.590 |
LIG_deltaCOP1_diTrp_1 | 426 | 432 | PF00928 | 0.478 |
LIG_FHA_2 | 1 | 7 | PF00498 | 0.555 |
LIG_FHA_2 | 291 | 297 | PF00498 | 0.336 |
LIG_FHA_2 | 412 | 418 | PF00498 | 0.667 |
LIG_FHA_2 | 9 | 15 | PF00498 | 0.488 |
LIG_LIR_Apic_2 | 493 | 497 | PF02991 | 0.527 |
LIG_LIR_Gen_1 | 132 | 142 | PF02991 | 0.451 |
LIG_LIR_Gen_1 | 256 | 265 | PF02991 | 0.321 |
LIG_LIR_Gen_1 | 323 | 331 | PF02991 | 0.443 |
LIG_LIR_Gen_1 | 426 | 437 | PF02991 | 0.485 |
LIG_LIR_Nem_3 | 211 | 217 | PF02991 | 0.321 |
LIG_LIR_Nem_3 | 256 | 262 | PF02991 | 0.421 |
LIG_LIR_Nem_3 | 305 | 309 | PF02991 | 0.549 |
LIG_LIR_Nem_3 | 32 | 36 | PF02991 | 0.552 |
LIG_LIR_Nem_3 | 323 | 327 | PF02991 | 0.308 |
LIG_LIR_Nem_3 | 426 | 432 | PF02991 | 0.501 |
LIG_LIR_Nem_3 | 66 | 72 | PF02991 | 0.471 |
LIG_LYPXL_yS_3 | 59 | 62 | PF13949 | 0.470 |
LIG_MYND_3 | 412 | 416 | PF01753 | 0.580 |
LIG_Pex14_2 | 33 | 37 | PF04695 | 0.560 |
LIG_PTB_Apo_2 | 27 | 34 | PF02174 | 0.450 |
LIG_SH2_CRK | 324 | 328 | PF00017 | 0.508 |
LIG_SH2_CRK | 69 | 73 | PF00017 | 0.473 |
LIG_SH2_STAP1 | 425 | 429 | PF00017 | 0.467 |
LIG_SH2_STAP1 | 64 | 68 | PF00017 | 0.440 |
LIG_SH2_STAT5 | 128 | 131 | PF00017 | 0.396 |
LIG_SH2_STAT5 | 153 | 156 | PF00017 | 0.322 |
LIG_SH2_STAT5 | 176 | 179 | PF00017 | 0.509 |
LIG_SH2_STAT5 | 204 | 207 | PF00017 | 0.428 |
LIG_SH2_STAT5 | 237 | 240 | PF00017 | 0.399 |
LIG_SH2_STAT5 | 263 | 266 | PF00017 | 0.386 |
LIG_SH2_STAT5 | 309 | 312 | PF00017 | 0.434 |
LIG_SH3_3 | 118 | 124 | PF00018 | 0.451 |
LIG_SH3_3 | 359 | 365 | PF00018 | 0.608 |
LIG_SH3_3 | 494 | 500 | PF00018 | 0.595 |
LIG_SUMO_SIM_par_1 | 162 | 168 | PF11976 | 0.448 |
LIG_SUMO_SIM_par_1 | 380 | 392 | PF11976 | 0.755 |
LIG_TRAF2_1 | 294 | 297 | PF00917 | 0.374 |
LIG_UBA3_1 | 330 | 336 | PF00899 | 0.361 |
MOD_CK1_1 | 159 | 165 | PF00069 | 0.399 |
MOD_CK1_1 | 386 | 392 | PF00069 | 0.670 |
MOD_CK1_1 | 395 | 401 | PF00069 | 0.588 |
MOD_CK1_1 | 461 | 467 | PF00069 | 0.676 |
MOD_CK1_1 | 63 | 69 | PF00069 | 0.384 |
MOD_CK1_1 | 93 | 99 | PF00069 | 0.523 |
MOD_CK2_1 | 290 | 296 | PF00069 | 0.368 |
MOD_CK2_1 | 8 | 14 | PF00069 | 0.690 |
MOD_Cter_Amidation | 334 | 337 | PF01082 | 0.364 |
MOD_GlcNHglycan | 104 | 107 | PF01048 | 0.501 |
MOD_GlcNHglycan | 348 | 351 | PF01048 | 0.764 |
MOD_GlcNHglycan | 456 | 459 | PF01048 | 0.611 |
MOD_GlcNHglycan | 484 | 487 | PF01048 | 0.687 |
MOD_GSK3_1 | 111 | 118 | PF00069 | 0.477 |
MOD_GSK3_1 | 286 | 293 | PF00069 | 0.321 |
MOD_GSK3_1 | 312 | 319 | PF00069 | 0.349 |
MOD_GSK3_1 | 370 | 377 | PF00069 | 0.634 |
MOD_GSK3_1 | 379 | 386 | PF00069 | 0.776 |
MOD_GSK3_1 | 388 | 395 | PF00069 | 0.673 |
MOD_GSK3_1 | 454 | 461 | PF00069 | 0.582 |
MOD_GSK3_1 | 482 | 489 | PF00069 | 0.701 |
MOD_GSK3_1 | 90 | 97 | PF00069 | 0.560 |
MOD_N-GLC_1 | 29 | 34 | PF02516 | 0.453 |
MOD_N-GLC_1 | 355 | 360 | PF02516 | 0.706 |
MOD_N-GLC_1 | 475 | 480 | PF02516 | 0.663 |
MOD_N-GLC_1 | 93 | 98 | PF02516 | 0.528 |
MOD_N-GLC_2 | 152 | 154 | PF02516 | 0.318 |
MOD_N-GLC_2 | 308 | 310 | PF02516 | 0.310 |
MOD_N-GLC_2 | 351 | 353 | PF02516 | 0.568 |
MOD_NEK2_1 | 115 | 120 | PF00069 | 0.445 |
MOD_NEK2_1 | 22 | 27 | PF00069 | 0.441 |
MOD_NEK2_1 | 231 | 236 | PF00069 | 0.446 |
MOD_NEK2_1 | 246 | 251 | PF00069 | 0.266 |
MOD_NEK2_1 | 316 | 321 | PF00069 | 0.466 |
MOD_NEK2_1 | 338 | 343 | PF00069 | 0.579 |
MOD_NEK2_1 | 352 | 357 | PF00069 | 0.598 |
MOD_NEK2_1 | 388 | 393 | PF00069 | 0.574 |
MOD_NEK2_1 | 475 | 480 | PF00069 | 0.736 |
MOD_PIKK_1 | 316 | 322 | PF00454 | 0.383 |
MOD_PIKK_1 | 375 | 381 | PF00454 | 0.520 |
MOD_PIKK_1 | 451 | 457 | PF00454 | 0.605 |
MOD_PK_1 | 383 | 389 | PF00069 | 0.622 |
MOD_PKA_1 | 156 | 162 | PF00069 | 0.389 |
MOD_PKA_1 | 218 | 224 | PF00069 | 0.321 |
MOD_PKA_1 | 490 | 496 | PF00069 | 0.536 |
MOD_PKA_2 | 111 | 117 | PF00069 | 0.508 |
MOD_PKA_2 | 156 | 162 | PF00069 | 0.377 |
MOD_PKA_2 | 395 | 401 | PF00069 | 0.635 |
MOD_PKA_2 | 461 | 467 | PF00069 | 0.532 |
MOD_PKA_2 | 490 | 496 | PF00069 | 0.536 |
MOD_Plk_1 | 115 | 121 | PF00069 | 0.455 |
MOD_Plk_1 | 389 | 395 | PF00069 | 0.594 |
MOD_Plk_4 | 115 | 121 | PF00069 | 0.448 |
MOD_Plk_4 | 159 | 165 | PF00069 | 0.458 |
MOD_Plk_4 | 383 | 389 | PF00069 | 0.730 |
MOD_ProDKin_1 | 290 | 296 | PF00069 | 0.438 |
MOD_ProDKin_1 | 400 | 406 | PF00069 | 0.596 |
MOD_ProDKin_1 | 493 | 499 | PF00069 | 0.627 |
MOD_SUMO_for_1 | 187 | 190 | PF00179 | 0.357 |
MOD_SUMO_for_1 | 50 | 53 | PF00179 | 0.458 |
MOD_SUMO_rev_2 | 283 | 292 | PF00179 | 0.404 |
MOD_SUMO_rev_2 | 35 | 44 | PF00179 | 0.377 |
MOD_SUMO_rev_2 | 63 | 68 | PF00179 | 0.387 |
TRG_DiLeu_BaEn_2 | 254 | 260 | PF01217 | 0.318 |
TRG_DiLeu_BaLyEn_6 | 380 | 385 | PF01217 | 0.614 |
TRG_ENDOCYTIC_2 | 135 | 138 | PF00928 | 0.403 |
TRG_ENDOCYTIC_2 | 214 | 217 | PF00928 | 0.321 |
TRG_ENDOCYTIC_2 | 324 | 327 | PF00928 | 0.439 |
TRG_ENDOCYTIC_2 | 59 | 62 | PF00928 | 0.484 |
TRG_ENDOCYTIC_2 | 69 | 72 | PF00928 | 0.484 |
TRG_ER_diArg_1 | 156 | 158 | PF00400 | 0.377 |
TRG_ER_diArg_1 | 327 | 329 | PF00400 | 0.462 |
TRG_NLS_Bipartite_1 | 42 | 59 | PF00514 | 0.392 |
TRG_NLS_MonoExtN_4 | 54 | 59 | PF00514 | 0.450 |
TRG_Pf-PMV_PEXEL_1 | 328 | 333 | PF00026 | 0.451 |
TRG_Pf-PMV_PEXEL_1 | 70 | 74 | PF00026 | 0.457 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I2H3 | Leptomonas seymouri | 33% | 100% |
A0A0N1IKB0 | Leptomonas seymouri | 32% | 89% |
A0A1X0NZS9 | Trypanosomatidae | 48% | 100% |
A0A1X0P176 | Trypanosomatidae | 37% | 100% |
A0A3Q8IJ66 | Leishmania donovani | 47% | 100% |
A0A3Q8ISA0 | Leishmania donovani | 44% | 100% |
A0A3S7WNZ6 | Leishmania donovani | 34% | 100% |
A0A3S7WZA2 | Leishmania donovani | 93% | 97% |
A0A422NL83 | Trypanosoma rangeli | 45% | 100% |
A4H436 | Leishmania braziliensis | 34% | 100% |
A4HEI6 | Leishmania braziliensis | 77% | 98% |
A4HFV0 | Leishmania braziliensis | 32% | 90% |
A4HIT6 | Leishmania braziliensis | 42% | 100% |
A4HMD0 | Leishmania braziliensis | 42% | 100% |
A4HMD1 | Leishmania braziliensis | 47% | 100% |
A4HSC0 | Leishmania infantum | 34% | 100% |
A4I1K4 | Leishmania infantum | 93% | 97% |
A4I638 | Leishmania infantum | 44% | 100% |
A4IAZ8 | Leishmania infantum | 47% | 100% |
C9ZK43 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 43% | 100% |
C9ZM31 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 30% | 73% |
E9AKA2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 34% | 100% |
E9AXN8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 97% |
E9B1C3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 43% | 100% |
E9B5Y1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 47% | 100% |
O96999 | Leishmania major | 33% | 100% |
P00521 | Abelson murine leukemia virus | 22% | 68% |
P39962 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 35% | 96% |
P42168 | Caenorhabditis elegans | 44% | 100% |
Q09437 | Caenorhabditis elegans | 27% | 70% |
Q4Q6U1 | Leishmania major | 44% | 100% |
Q62761 | Rattus norvegicus | 43% | 100% |
Q86Y07 | Homo sapiens | 25% | 99% |
Q8BN21 | Mus musculus | 28% | 100% |
Q8BTH8 | Mus musculus | 43% | 100% |
Q8C4X2 | Mus musculus | 37% | 100% |
Q8VYK9 | Arabidopsis thaliana | 44% | 100% |
Q9NHE1 | Leishmania major | 47% | 100% |
V5BMQ3 | Trypanosoma cruzi | 39% | 100% |